Critical Care Innovations (CCI), a biotechnology-driven device company, is developing minimally-invasive, site-specific and image-guided cancer management systems.
By using ultrasound guidance and visualization technologies, along with its proprietary cryothermal and microencapsulation processes, the company has created a unique, site-specific and controlled release cancer management diagnostic and therapeutic system.
The company’s microencapsulated controlled delivery process can deliver, with accuracy, individualized therapeutic and concentrated doses of chemotherapeutics directly into targeted regions of the patient’s cancerous tissue, providing sustained release of drugs. By encapsulating drugs, CCI has improved the effectiveness of chemotherapy, lowering toxicity and virtually eliminating side effects.